SCHEMBL30798035

SCHEMBL30798035

N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 2/20 0.41
▸ GNPAT O15228 1/20 0.36
▸ ENPEP Q07075 6/20 0.36
▸ PLA2G2A P14555 1/20 0.35
▸ CA2 P00918 2/20 0.34
▸ CA1 P00915 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ECE1 P42892 1/20 0.34
▸ CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477911 0.98 MME (0.39) MMEGNPATENPEPPLA2G2ACA2
SCHEMBL29360643 0.97 MME (0.42) MMEGNPATENPEPCA2CA1
SCHEMBL30859432 0.96 MME (0.40) MMEGNPATENPEPPLA2G2ACA2
SCHEMBL29510840 0.96 MME (0.38) MMEGNPATENPEP
SCHEMBL31707374 0.95 MME (0.38) MMEGNPATENPEPECE1
SCHEMBL29598237 0.94 MME (0.40) MMEGNPATENPEPCA2CA1
SCHEMBL30038078 0.94 MME (0.39) MMEGNPATENPEPCA2CA1
SCHEMBL29761682 0.93 MME (0.43) MMEGNPATENPEPPLA2G2A
SCHEMBL31310661 0.92 MME (0.38) MMEGNPATENPEP
SCHEMBL30477912 0.92 MME (0.40) MMEGNPATENPEPPLA2G2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240247028-A1 PEPTIDE COMPOSITIONS FOR SLOWING DEGRADATION OF VITAMIN MINERAL SUPPLEMENTS, FOODS, PHARMACEUTICAL AND COSMETICS BAILEY STEVEN W (US) 2024-07-25 — — US disclosed
US-11912785-B2 Peptide compositions for slowing degradation of vitamin mineral supplements, foods, pharmaceutical and cosmetics BAILEY STEVEN W (US) 2024-02-27 — — US disclosed
Send feedback